Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,779,938
-
Total 13F shares
-
20,300,819
-
Share change
-
+20,298,812
-
Total reported value
-
$647,804,482
-
Put/Call ratio
-
67%
-
Price per share
-
$31.88
-
Number of holders
-
89
-
Value change
-
+$647,740,494
-
Number of buys
-
88
Institutional Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q2 2014
As of 30 Jun 2014,
Theravance Biopharma, Inc. - Common Stock (TBPH) was held by
89 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,300,819 shares.
The largest 10 holders included
BAUPOST GROUP LLC/MA, IRIDIAN ASSET MANAGEMENT LLC/CT, VANGUARD GROUP INC, OPPENHEIMER FUNDS INC, BlackRock Fund Advisors, CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD, BlackRock Institutional Trust Company, N.A., State Street Corp, FMR LLC, and EAGLE ASSET MANAGEMENT INC.
This page lists
89
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.